Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

TQB3455 Plus Azacitidine in Patients with Newly Diagnosed, Mutant-IDH2 Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Phase 1 Trial

Wenbing Duan, Chunkang Chang, Zhiguo Wang, Hongbing Ma, Min Ouyang, Xingli Zhao, Lifan Tu, Guodong Wu, Xunqiang Wang, Xiao Jun Huang, Hao Jiang

Blood (2024) 144 (Supplement 1): 1504.

https://doi.org/10.1182/blood-2024-204972

Published: 2024

Journal Articles

Venetoclax Plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for Elderly or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia: A Multicenter, Prospective Study

Hongbing Ma, Yiwen Du, Jianjun Li, Jin Rao, Yong Guo, Yunfan Yang, Duanzhong Zhang, Jia Wang, Yi Liao, Yuping Gong

Blood (2024) 144 (Supplement 1): 2898.

https://doi.org/10.1182/blood-2024-202318

Published: 2024

Journal Articles

Single-Center Retrospective Clinical Evaluation of 7-Day Venetoclax Combined with Decitabine and CAG Regimen for AML Older Than 60 Years

Yong Guo, Yiwen Du, Hongbing Ma, Yuping Gong, Ting Niu

Blood (2024) 144 (Supplement 1): 6006.

https://doi.org/10.1182/blood-2024-207662

Published: 2024

Journal Articles

Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS)

Huafeng Wang, Xudong Wei, Yang Liang, Jianyu Weng, Wenjuan He, Chunkang Chang, Suning Chen, Hongbing Ma, Zi Chen, Lichuang Men, Lihui Liu, Xiaohong Tian, Zhang Zhang, Danhua Cong, Dajun Yang, Yifan Zhai, Jie Jin

Blood (2024) 144 (Supplement 1): 3202.

https://doi.org/10.1182/blood-2024-205371

Published: 2024

Journal Articles

Safety and Efficacy of Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor (BCL-2i), in Relapsed or Refractory (R/R) or Treatment-Naïve (TN) Patients (Pts) with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Other Myeloid Neoplasms

Blood (2023) 142 (Supplement 1): 2925.

https://doi.org/10.1182/blood-2023-188489

Published: 2023

Journal Articles

Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia

Qi Zhang, He Li, Xuelan Chen, Fan Gu, Lanxin Zhang, Lu Zhang, Tong Chen, Qiang Chen, Wentong Meng, Yu Wu, Hong Chang, Ting Liu, Chong Chen, Hongbing Ma, Yu Liu

Blood (2023) 142 (17): 1494–1499.

https://doi.org/10.1182/blood.2023020619

Published: 2023

Includes: Supplemental data

Journal Articles

Phase I Study of TQB3455, a Selective Inhibitor of IDH2 with Favorable Safety and More Potent Efficacy to IDH2-R172K Mutation, for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Hao Jiang, Xudong Wei, Chunkang Chang, Hongbing Ma, Xuejun Zhang, Xiao-Jun Huang

Blood (2022) 140 (Supplement 1): 9082–9083.

https://doi.org/10.1182/blood-2022-164984

Published: 2022

Journal Articles

Cord Blood T Regulatory Cells Can Dampen Cytokine Release Syndrome and Improve on Target Efficacy of CD19 CAR T Cells

Ke Zeng, MD, Li Li, MD, Meixian Huang, MD,PhD, Mi-Ae Lyu, PhD, Mitsutaka Nishimoto, MD, PhD, Hongbing Ma, MD, PhD, Tara Sadeghi, Loretta J. Nastoupil, MD, Krina K. Patel, MD, Sairah Ahmed, MD, Simrit Parmar, MD, MSCI

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-138812

Published: 2020

Journal Articles

Adoptive Therapy with Cord Blood T Regulatory Cells Enhances Anti-Myeloma Efficacy of T Cell Based Immunotherapies

Mitsutaka Nishimoto, MD PhD, Li Li, MD, Meixian Huang, MD,PhD, Mi-Ae Lyu, PhD, Ke Zeng, MD, Hongbing Ma, MD PhD, Tara Sadeghi, Sairah Ahmed, MD, Nina Shah, MD, Krina K. Patel, MD, Simrit Parmar, MD, MSCI

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-143142

Published: 2020

Journal Articles

Combination of Cord Blood T Regulatory Cells with Ruxolitinib Decreases Side Effects and Improves Survival in Xenogenic Graft Vs. Host Disease

Ke Zeng, MD, Meixian Huang, MD,PhD, Li Li, MD, Mi-Ae Lyu, PhD, Hongbing Ma, MD, Mitsutaka Nishimoto, MD,PhD, Tara Sadeghi, Sairah Ahmed, MD, Borje S. Andersson, MD, PhD, Simrit Parmar, MD, MSCI

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-140417

Published: 2020

Journal Articles

Adoptive Cord Blood T Regulatory Cell Therapy Leads to Resolution of Inflammation and Decreased Proteinuria in Lupus Nephritis

Mi-Ae Lyu, PhD, Joseph D. Khoury, MD, Meixian Huang, MD,PhD, Mitsutaka Nishimoto, MD PhD, Ke Zeng, MD, Li Li, MD, Hongbing Ma, MD PhD, Tara Sadeghi, Simrit Parmar, MD, MSCI

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-140420

Published: 2020

Journal Articles

Adoptive Therapy with Cord Blood Regulatory T Cells Can Treat Graft Vs Host Disease

Hongbing Ma, MD PhD, Ke Zeng, MD PhD, Mitsutaka Nishimoto, MD PhD, Mi-Ae Lyu, PhD, Meixian Huang, Swaminathan P. Iyer, MD, Simrit Parmar, MBBS

Blood (2019) 134 (Supplement_1): 1940.

https://doi.org/10.1182/blood-2019-129395

Published: 2019

Journal Articles

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Tapan M. Kadia, MD, Hongbing Ma, MD PhD, Ke Zeng, MD PhD, Mitsutaka Nishimoto, MD PhD, Mi-Ae Lyu, PhD, Meixian Huang, Musa Yilmaz, MD, Courtney D. DiNardo, MDMSc, Ghayas C. Issa, MD, Simrit Parmar, MBBS, Swami P. Iyer, MD, Parameswaran Hari, MBBS, MD, Naval G. Daver, MD, Elias Jabbour, MD, Gautam M. Borthakur, MD, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 1221.

https://doi.org/10.1182/blood-2019-127702

Published: 2019

Journal Articles

Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial

Ke Zeng, MD PhD, Hongbing Ma, MD PhD, Uday Popat, MD, Yago Nieto, MD PhD, Stefan O. Ciurea, MD, Amanda L. Olson, MD, Mi-Ae Lyu, PhD, Meixian Huang, Mitsutaka Nishimoto, MD PhD, Muzaffar H. Qazilbash, MD, Jennifer D Ramos, RN, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Simrit Parmar, MBBS, Borje S Andersson, MD PhD

Blood (2019) 134 (Supplement_1): 4547.

https://doi.org/10.1182/blood-2019-127726

Published: 2019

Journal Articles

Novel CD4 + CD8 + Umbilical Cord Blood Regulatory T Cells

Meixian Huang, Amit Verma, MBBS, Ke Zeng, MD PhD, Mi-Ae Lyu, PhD, Mitsutaka Nishimoto, MD PhD, Hongbing Ma, MD PhD, Zheng Yin, PhD, Swaminathan P. Iyer, MD, Simrit Parmar, MBBS

Blood (2019) 134 (Supplement_1): 4446.

https://doi.org/10.1182/blood-2019-131948

Published: 2019

Journal Articles

Adoptive Therapy with Cord Blood Regulatory T Cells Does Not Impair Anti-Leukemia Activity of Infused Donor Cells

Hongbing Ma, MD, Mitsutaka Nishimoto, MD PhD, Ke Zeng, PhD, Tuongvan D Nguyen, William Schuler, Joshua Kellner, Jaimol Peedikayil, PhD, Mi-Ae Lyu, Santhana Thangavelu-Devaraj, Simrit Parmar, MBBS

Blood (2018) 132 (Supplement 1): 5214.

https://doi.org/10.1182/blood-2018-99-119239

Published: 2018

Journal Articles

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Blood (2016) 128 (22): 4882.

https://doi.org/10.1182/blood.V128.22.4882.4882

Published: 2016

Journal Articles

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

Ling Pan, MD, PhD, Meng Chen, Yongqian Jia, MD, PhD, Xu Cui, MD, Ting Niu, MD, PhD, Hong Chang, MD, PhD, Hongbing Ma, MD, Jianjun Li, MD, Yuping Gong, MD, PhD, Xinchuan Chen, MD, Ting Liu, MD, PhD

Blood (2013) 122 (21): 5001.

https://doi.org/10.1182/blood.V122.21.5001.5001

Published: 2013

Journal Articles

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

Pu Kuang, MD, PhD, Yu Wu, MD, PhD, Bing Xiang, MD, Hongbing Ma, MD, Hong Chang, MD, Ting Niu, MD, PhD, Xu Cui, MD, Chuan He, MD, Jianjun Li, MD, Jie Ji, MD, Jie Huang, MD, Tian Dong, MD, PhD, Qing Shenglan, MB, Huaxin Wu, MB, Xiaogong Liang, MSc, Haiying Guo, MB, Chunnong Wu, MB, Ting Liu, MD

Blood (2013) 122 (21): 5019.

https://doi.org/10.1182/blood.V122.21.5019.5019

Published: 2013

Journal Articles

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Ting Liu, MD, Pu Kuang, MD, Tian Dong, MD, Bing Xiang, MD, Jianjun Li, MD, Xinchuan Chen, MD, Chuan He, MD, Hongbing Ma, MD, Jie Ji, MD, Yuping Gong, MD, PhD, Hong Chang, MD, Yu Wu, MD, PhD, Huanling Zhu, MD, Yuchun Wang, MD, PhD

Blood (2011) 118 (21): 4243.

https://doi.org/10.1182/blood.V118.21.4243.4243

Published: 2011

NARROW

TQB3455 Plus Azacitidine in Patients with Newly Diagnosed, Mutant-IDH2 Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Phase 1 Trial

Venetoclax Plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for Elderly or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia: A Multicenter, Prospective Study

Single-Center Retrospective Clinical Evaluation of 7-Day Venetoclax Combined with Decitabine and CAG Regimen for AML Older Than 60 Years

Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS)

Safety and Efficacy of Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor (BCL-2i), in Relapsed or Refractory (R/R) or Treatment-Naïve (TN) Patients (Pts) with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Other Myeloid Neoplasms

Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia

Phase I Study of TQB3455, a Selective Inhibitor of IDH2 with Favorable Safety and More Potent Efficacy to IDH2-R172K Mutation, for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Cord Blood T Regulatory Cells Can Dampen Cytokine Release Syndrome and Improve on Target Efficacy of CD19 CAR T Cells

Adoptive Therapy with Cord Blood T Regulatory Cells Enhances Anti-Myeloma Efficacy of T Cell Based Immunotherapies

Combination of Cord Blood T Regulatory Cells with Ruxolitinib Decreases Side Effects and Improves Survival in Xenogenic Graft Vs. Host Disease

Adoptive Cord Blood T Regulatory Cell Therapy Leads to Resolution of Inflammation and Decreased Proteinuria in Lupus Nephritis

Adoptive Therapy with Cord Blood Regulatory T Cells Can Treat Graft Vs Host Disease

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial

Novel CD4 + CD8 + Umbilical Cord Blood Regulatory T Cells

Adoptive Therapy with Cord Blood Regulatory T Cells Does Not Impair Anti-Leukemia Activity of Infused Donor Cells

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only